Latest News about GSK
Recent news which mentions GSK
One Year Into Kabir Nath's Leadership, Compass Pathways' (NASDAQ: CMPS) Phase 3 Trial For Innovative Treatment Resistant Depression Progressing
September 18, 2023
From Benzinga
Pleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology Deal
September 18, 2023
Tickers
GSK
From Benzinga
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
September 14, 2023
From Benzinga
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
September 13, 2023
From InvestorPlace
Moderna aims to prove it’s ‘more than a COVID company’
September 13, 2023
From MarketWatch
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
From Benzinga
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
September 09, 2023
From Motley Fool
Vivek Ramaswamy's Parallels With Warren Buffett Run Deeper Than Wanting To Make Roivant The 'Berkshire Hathaway Of Drug Development'
September 04, 2023
From Benzinga
7 Stocks Hedge Funds Are Loading Up On
September 03, 2023
From InvestorPlace
3 Growth Stocks to Ride the Coming Bull Market in Style
August 26, 2023
From InvestorPlace
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
From InvestorPlace
From Benzinga
Pfizer maternal RSV vaccine gets FDA approval
August 21, 2023
From MarketWatch
Tickers
GSK
From Motley Fool
3 Pharma Stocks to Sell in August Before They Crash and Burn
August 11, 2023
From InvestorPlace
GSK, Pfizer Lock Horns Over Patent Fight Related To Respiratory Syncytial Virus Vaccine
August 02, 2023
From Benzinga
GSK's Jemperli Plus Chemo Combo Scores FDA Approval As First New Frontline Treatment For Certain Type Of Endometrial Cancer
August 01, 2023
Tickers
GSK
From Benzinga
From InvestorPlace
From InvestorPlace
Is GSK Stock Worth Buying Right Now?
July 29, 2023
From Motley Fool
GSK Says 'Excellent' Q2 Performance Boosted By Vaccine & HIV Drug Sales, Raises 2023 Outlook
July 26, 2023
Tickers
GSK
From Benzinga
From Benzinga
GSK-Pfizer Backed HIV-Focused Unit ViiV Healthcare's Cabotegravir Injected Drug, Tablets Secure European Backing For Approval
July 24, 2023
From Benzinga
From InvestorPlace
Why Shares of Vir Biotechnology Are Plunging Thursday
July 20, 2023
From Motley Fool